Menu
  • Join
  • Login
  • Contact
 

Search abstracts


EVALUATE THE DOSE ADJUSTMENT OF NAS IN CHB PATIENT WITH RENAL IMPAIRMENT.

  • At: 2015 FIP Congress in Düsseldorf (Germany)
  • Type: Poster
  • By: TING, Yuling (SiJhih Cathay General Hospital, Pharmacy, New Taipei City, China Taiwan)
  • Co-author(s): Yu-Ling Ting
  • Abstract:

    According to American association for the study of liver diseases (AASLD) 2009 Guidelines on Chronic Hepatitis B (CHB), the dosage of oral nucleoside or nucleotide analogues (NAs) should adjust when patient’s creatinine clearance (CrCl)<50ml/min.

     

    We retrospectively collected all the prescriptions of NAs from November 1, 2013 to October 31, 2014.


    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses